Cargando…
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
BACKGROUND: Drug repurposing is a valuable strategy for rapidly developing drugs for treating COVID-19. This study aimed to evaluate the antiviral effect of six antiretrovirals against SARS-CoV-2 in vitro and in silico. METHODS: The cytotoxicity of lamivudine, emtricitabine, tenofovir, abacavir, efa...
Autores principales: | Zapata-Cardona, Maria I., Florez-Alvarez, Lizdany, Guerra-Sandoval, Ariadna L., Chvatal-Medina, Mateo, Guerra-Almonacid, Carlos M., Hincapie-Garcia, Jaime, Hernandez, Juan C., Rugeles, Maria T., Zapata-Builes, Wildeman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988408/ https://www.ncbi.nlm.nih.gov/pubmed/36891537 http://dx.doi.org/10.3934/microbiol.2023002 |
Ejemplares similares
-
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
por: Zapata-Cardona, María I., et al.
Publicado: (2022) -
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022) -
NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity
por: Rincón, Daniel S., et al.
Publicado: (2023) -
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
por: Lopera, Tulio J., et al.
Publicado: (2022) -
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
por: Marín-Palma, Damariz, et al.
Publicado: (2021)